Sacca F, Barnett C, Vu T, Peric S, et al. Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT). J Neurol 2023 Jan 4. doi: 10.1007/s00415-022-11517.
PMID: 36598575